Tissue expression and functional insights into HIF prolyl hydroxylase domain enzymes

Tissue expression and functional insights into HIF prolyl hydroxylase domain enzymes

<p>This research programme investigated the expression of prolyl hydroxylase (PHD) proteins in rodent tissues. The importance of PHD enzymes lies in their ability to render oxygen sensitivity to Hypoxia inducible factor (HIF), the principal mediator of intracellular oxygen homeostasis. The fir...

書誌詳細
第一著者:	Wijeyekoon, JB
その他の著者:	Pugh, C
フォーマット:	学位論文
言語:	English
出版事項:	2013
主題:	Medical Sciences Clinical laboratory sciences

類似資料

Regulation of HIF: prolyl hydroxylases.
著者:: Stolze, I, 等
出版事項: (2006)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
著者:: Chowdhury, R, 等
出版事項: (2016)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
著者:: Rasheduzzaman Chowdhury, 等
出版事項: (2016-08-01)

Tolerance in renal transplantation: is mixed chimerism the missing link?
著者:: Janes, S, 等
出版事項: (2009)

The use of dioxygen by HIF prolyl hydroxylase (PHD1).
著者:: McNeill, L, 等
出版事項: (2002)

Determination and comparison of specific activity of the HIF-prolyl hydroxylases.
著者:: Tuckerman, JR, 等
出版事項: (2004)

2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
著者:: Mole, D, 等
出版事項: (2003)

Analogues of dealanylalahopcin are inhibitors of human HIF prolyl hydroxylases.
著者:: Schlemminger, I, 等
出版事項: (2003)

Studies on HIF hydroxylases
著者:: Webb, J
出版事項: (2008)

Structure–activity relationship and crystallographic studies on 4-hydroxypyrimidine HIF prolyl hydroxylase domain inhibitors
著者:: Holt-Martyn, JP, 等
出版事項: (2019)

Cortical dynamics subserving visual apparent motion
著者:: Ahmed, B, 等
出版事項: (2008)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
著者:: Cockman, M, 等
出版事項: (2019)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
著者:: Matthew E Cockman, 等
出版事項: (2019-09-01)

Prolyl hydroxylase domain enzyme PHD2 inhibits proliferation and metabolism in non-small cell lung cancer cells in HIF-dependent and HIF-independent manners
著者:: Hongyan Deng, 等
出版事項: (2024-06-01)

Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases
著者:: Chan, M, 等
出版事項: (2016)

Molecular and Cellular Mechanisms of HIF Prolyl Hydroxylase inhibitors in Clinical Trials
著者:: Yeh, TL, 等
出版事項: (2017)

Neuroprotective Effect of HIF Prolyl Hydroxylase Inhibition in an In Vitro Hypoxia Model
著者:: Maria Savyuk, 等
出版事項: (2020-07-01)

HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
著者:: Andrey A. Poloznikov, 等
出版事項: (2021-01-01)

Novel and selective small molecule inhibitors and activators for the prolyl hydroxylase domain enzyme
著者:: Holt-Martyn, J
出版事項: (2018)

The role of CCL25 and CCR9 in intestinal inflammation
著者:: Wendt, E, 等
出版事項: (2013)

Adaptive changes of influenza virus A/H5N1 neuraminidase in vitro and in vivo
著者:: Le Nguyen, T
出版事項: (2014)

Angiogenesis in human lung tumours
著者:: Ferguson, ML
出版事項: (2008)

Editorial commentary: Understanding BCG is the key to improving it
著者:: McShane, H
出版事項: (2014)

Human T-lymphotropic virus type 1(HTLV-1) associated infective dermatitis
著者:: Hlela, C
出版事項: (2011)

Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
著者:: Flashman, E, 等
出版事項: (2010)

Therapeutic Effect of Extracellular Vesicles Derived from HIF Prolyl Hydroxylase Domain Enzyme Inhibitor-Treated Cells on Renal Ischemia/Reperfusion Injury
著者:: Zhao-Ying Ding, 等
出版事項: (2022-03-01)

Probing the molecular basis of melanopsin induced light sensitivity
著者:: Vachtsevanos, AN
出版事項: (2012)

Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases.
著者:: Chowdhury, R, 等
出版事項: (2013)

Structural, biochemical and inhibition studies on hypoxia-inducible factor (HIF) prolyl hydroxylases
著者:: Lippl, K
出版事項: (2018)

HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O(2) levels.
著者:: Masson, N, 等
出版事項: (2003)

Impact of HIF prolyl hydroxylase inhibitors in heart failure patients with renal anemia
著者:: Takahiro Kambara, 等
出版事項: (2024-03-01)

HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
著者:: Kiichi Hirota
出版事項: (2021-04-01)

The HIF-prolyl hydroxylases have distinct and nonredundant roles in colitis-associated cancer
著者:: Kilian B. Kennel, 等
出版事項: (2022-11-01)

HR23B, a biomarker for HDAC inhibitors
著者:: Khan, OA
出版事項: (2013)

Risk factors for haemorrhage in patients with haematological malignancies
著者:: Estcourt, LJ
出版事項: (2014)

HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation.
著者:: Willam, C, 等
出版事項: (2006)

Mechanistic studies on human prolyl hydroxylase domain 2
著者:: Fiorini, G
出版事項: (2024)

Structural basis of prolyl hydroxylase domain inhibition by Molidustat
著者:: Figg, WD, 等
出版事項: (2021)

Role of prolyl hydroxylase domain proteins in bone metabolism
著者:: David Wolf, 等
出版事項: (2022-03-01)

Transcription regulation of Nrp1 during endothelial cell differentiation
著者:: Zhao, Z
出版事項: (2014)